Cargando…

Characterization of SARS-CoV-2 Evasion: Interferon Pathway and Therapeutic Options

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for the current COVID-19 pandemic. SARS-CoV-2 is characterized by an important capacity to circumvent the innate immune response. The early interferon (IFN) response is necessary to establish a robust antiviral state. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Znaidia, Mariem, Demeret, Caroline, van der Werf, Sylvie, Komarova, Anastassia V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231409/ https://www.ncbi.nlm.nih.gov/pubmed/35746718 http://dx.doi.org/10.3390/v14061247

Ejemplares similares

SARS-CoV-2-mediated evasion strategies for antiviral interferon pathways
por: Oh, Soo-Jin, et al.
Publicado: (2022)

Evasion of Type I Interferon by SARS-CoV-2
por: Xia, Hongjie, et al.
Publicado: (2020)

Activation and evasion of type I interferon responses by SARS-CoV-2
por: Lei, Xiaobo, et al.
Publicado: (2020)

Immune evasion of SARS-CoV-2 from interferon antiviral system
por: Min, Yuan-Qin, et al.
Publicado: (2021)

Interferon induction, evasion, and paradoxical roles during SARS‐CoV‐2 infection
por: Chiale, Carolina, et al.
Publicado: (2022)

SARS-CoV-2 Evasion of the Interferon System: Can We Restore Its Effectiveness?
por: Sacchi, Alessandra, et al.
Publicado: (2023)

Nasopharyngeal and serological anti SARS-CoV-2 IgG/IgA responses in COVID-19 patients
por: Crescenzo-Chaigne, Bernadette, et al.
Publicado: (2021)

Ten Strategies of Interferon Evasion by Viruses
por: García-Sastre, Adolfo
Publicado: (2017)

Interferons: Signaling, antiviral and viral evasion
por: Bonjardim, Cláudio A., et al.
Publicado: (2009)

Molecular Perspectives of SARS-CoV-2: Pathology, Immune Evasion, and Therapeutic Interventions
por: Shah, Masaud, et al.
Publicado: (2021)

Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron
por: Cui, Zhen, et al.
Publicado: (2022)

Evasion of the Interferon-Mediated Antiviral Response by Filoviruses
por: Cárdenas, Washington B.
Publicado: (2010)

Evasion of interferon-mediated immune response by arteriviruses
por: Jian, Zhijie, et al.
Publicado: (2022)

Nonproteolytic K29-Linked Ubiquitination of the PB2 Replication Protein of Influenza A Viruses by Proviral Cullin 4-Based E3 Ligases
por: Karim, Marwah, et al.
Publicado: (2020)

Role of toll-like receptor 7/8 pathways in regulation of interferon response and inflammatory mediators during SARS-CoV2 infection and potential therapeutic options
por: Dyavar, Shetty Ravi, et al.
Publicado: (2021)

The Heterogeneous Landscape and Early Evolution of Pathogen-Associated CpG Dinucleotides in SARS-CoV-2
por: Di Gioacchino, Andrea, et al.
Publicado: (2021)

Molecular mechanisms involved in pathogenicity of SARS-CoV-2: Immune evasion and implications for therapeutic strategies
por: Latifi-Pupovci, Hatixhe
Publicado: (2022)

Interferon Response and Viral Evasion by Members of the Family Rhabdoviridae
por: Faul, Elizabeth J., et al.
Publicado: (2009)

Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
por: Castro, Flávia, et al.
Publicado: (2018)

Mechanisms of Antiviral Immune Evasion of SARS-CoV-2
por: Beyer, Daniel K., et al.
Publicado: (2022)

SARS-COV-2 Variants: Differences and Potential of Immune Evasion
por: Hirabara, Sandro M., et al.
Publicado: (2022)

SARS-CoV-2: A Master of Immune Evasion
por: Rubio-Casillas, Alberto, et al.
Publicado: (2022)

Immune Evasion of SARS-CoV-2 Omicron Subvariants
por: Ke, Hanzhong, et al.
Publicado: (2022)

Innate immune evasion strategies of SARS-CoV-2
por: Minkoff, Judith M., et al.
Publicado: (2023)

The Regulatory Network of Cyclic GMP-AMP Synthase-Stimulator of Interferon Genes Pathway in Viral Evasion
por: Hu, Tongyu, et al.
Publicado: (2021)

Differential Regulation of Type I Interferon and Epidermal Growth Factor Pathways by a Human Respirovirus Virulence Factor
por: Caignard, Grégory, et al.
Publicado: (2009)

The ORF8 protein of SARS-CoV-2 induced endoplasmic reticulum stress and mediated immune evasion by antagonizing production of interferon beta
por: Rashid, Farooq, et al.
Publicado: (2021)

Recent advances in understanding viral evasion of type I interferon
por: Taylor, Kathryne E., et al.
Publicado: (2013)

Evasion of I Interferon-Mediated Innate Immunity by Pseudorabies Virus
por: Zhang, Rui, et al.
Publicado: (2021)

A Comprehensive, Flexible Collection of SARS-CoV-2 Coding Regions
por: Kim, Dae-Kyum, et al.
Publicado: (2020)

Antibody evasion by the P.1 strain of SARS-CoV-2
por: Dejnirattisai, Wanwisa, et al.
Publicado: (2021)

Evolution of enhanced innate immune evasion by SARS-CoV-2
por: Thorne, Lucy G., et al.
Publicado: (2021)

Antibody evasion properties of SARS-CoV-2 Omicron sublineages
por: Iketani, Sho, et al.
Publicado: (2022)

The role of SARS-CoV-2 accessory proteins in immune evasion
por: Zandi, Milad, et al.
Publicado: (2022)

Immune evasion of neutralizing antibodies by SARS-CoV-2 Omicron
por: Wang, Lidong, et al.
Publicado: (2023)

High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in-hospital workers - The CoV-CONTACT cohort
por: Tubiana, Sarah, et al.
Publicado: (2021)

Clash of the titans: interferons and SARS-CoV-2
por: Jouvenet, Nolwenn, et al.
Publicado: (2021)

Influenza A virus co-opts ERI1 exonuclease bound to histone mRNA to promote viral transcription
por: Declercq, Marion, et al.
Publicado: (2020)

Crosstalk between interferon and interleukin-1 antiviral signaling in cancer cells: implications for immune evasion and therapeutic resistance
por: Gjerstorff, Morten Frier
Publicado: (2023)

SARS-CoV-2, Hypoxia, and Calcium Signaling: The Consequences and Therapeutic Options
por: Danta, Chhanda Charan
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qkhi0gml4ie1m1ujksgjgg5bdr